Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer-Reference-Cited by-同舟云学术

Investigating periprostatic adipose tissue as a driving force of prostate cancer progression: a new source of information for the advancement of targeted therapy in metastatic prostate cancer

Published:2023-03-27 Issue:3 Volume:34 Page:245-247
ISSN:0792-6855
Container-title:Journal of Basic and Clinical Physiology and Pharmacology
language:en
Short-container-title:

Author:

La Civita Evelina¹,Carbone Gianluigi¹,Sicignano Enrico²^ORCID,Crocetto Felice²,Terracciano Daniela¹^ORCID

Affiliation:

1. Department of Translational Medical Sciences , University of Naples “Federico II” , Naples , Italy

2. Department of Neuroscience and Reproductive and Odontostomatological Sciences , University of Naples “Federico II” , Naples , Italy

Publisher

Walter de Gruyter GmbH

Subject

Drug Discovery,Pharmacology,General Medicine,Physiology

Link

https://www.degruyter.com/document/doi/10.1515/jbcpp-2023-0059/pdf

Reference12 articles.

1. Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca Cancer J Clin 2021;71:209–49. https://doi.org/10.3322/caac.21660.

2. Scheinberg, T, Mak, B, Butler, L, Selth, L, Horvath, LG. Targeting lipid metabolism in metastatic prostate cancer. Ther Adv Med Oncol 2023;15:17588359231152839. https://doi.org/10.1177/17588359231152839.

3. van Roermund, JG, Bol, GH, Witjes, JA, Ruud Bosch, JL, Kiemeney, LA, van Vulpen, M. Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness. World J Urol 2010;28:699–704. https://doi.org/10.1007/s00345-009-0497-7.

4. Sacca, PA, Calvo, JC. Periprostatic adipose tissue microenvironment: metabolic and hormonal pathways during prostate cancer progression. Front Endocrinol 2022;13:863027. https://doi.org/10.3389/fendo.2022.863027.

5. Seruga, B, Ocana, A, Tannock, IF. Drug resistance in metastatic castration-resistant prostate cancer. Nat Rev Clin Oncol 2011;8:12–23. https://doi.org/10.1038/nrclinonc.2010.136.